Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × trastuzumab deruxtecan × Clear all

NCT07151586 2025-09-03

ALTER

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT05953168 2023-07-19

T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low Patients

Phase 2 Not yet recruiting

Triple Negative Breast Neoplasms